IMCD Stock

IMCD EV/EBITDA

The EV/EBITDA (Enterprise Value to EBITDA) of IMCD (IMCD.AS) as of Aug 22, 2026 is 14.18. In the previous year, EV/EBITDA (Enterprise Value to EBITDA) was 11.74 — a change of 20.82% (higher).

EV/EBITDA

14.18

YoY

20.82%

Last updated:

EV/EBITDA (Enterprise Value to EBITDA) of IMCD is 2026 14.18 . EV/EBITDA (Enterprise Value to EBITDA) of IMCD was 2025 11.74 . It decreases by 20.82% higher compared to the previous year.

The IMCD EV/EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/EBITDA
Date
EV/EBITDA
Jan 1, 2018
29.29 EUR
Jan 1, 2019
25.20 EUR
Jan 1, 2020
22.42 EUR
Jan 1, 2021
15.16 EUR
Jan 1, 2022
10.87 EUR
Jan 1, 2023
12.14 EUR
Jan 1, 2024
11.74 EUR
Jan 1, 2025
14.18 EUR
The IMCD EV/EBITDA history
YEAREV/EBITDAYoY
14.18+20.82%
11.74-3.32%
12.14+11.72%
10.87-28.31%
15.16-32.39%
22.42-11.04%
25.20-13.95%
29.29-18.64%
36.00-2.05%
36.75-21.88%
47.05-12.04%
53.49
Access this data via the Eulerpool API

IMCD Stock analysis

What does IMCD do? IMCD NV is a leading global distributor of specialty chemicals and food ingredients with over 100 years of experience in the industry. The company, founded in 1995, is headquartered in Rotterdam, Netherlands, and operates business in over 50 countries worldwide. History: IMCD was founded as an intermediary for pharmaceuticals and specialty chemicals, initially under the name Internatio-Müller. The company grew rapidly and expanded its product offering. In 1995, the company was renamed IMCD and began to further diversify in various areas, including Coatings & Construction, Life Sciences, Personal Care, and Food & Nutrition. Business model: IMCD offers a wide range of specialty and raw materials from leading manufacturers. The company provides customized services, including consultation, logistics, and technical support. They work closely with their customers and suppliers to support product development and application solutions. Segments: IMCD is divided into five main areas: Pharmaceuticals, Coatings & Construction, Life Sciences, Personal Care, and Food & Nutrition. Pharmaceuticals: IMCD offers a wide range of active ingredients, excipients, and granulates for the pharmaceutical industry. This includes API's (Active Pharmaceutical Ingredients), excipients, additives, and formulations. The products are offered for most areas of human and veterinary pharmacy. Coatings & Construction: IMCD offers solutions for the areas of paints, coatings, and construction. The company has extensive expertise in the formulation of coatings, paints, and coatings, as well as application technology and software-based color measurements. Life Sciences: IMCD offers a comprehensive range of specialty chemicals and raw materials for biotechnology, diagnostics, and analytics. The products are suitable for applications in medical diagnostics, biopharmaceutical production, and medical research. Personal Care: IMCD is a major supplier of raw materials and formulations for fragrant cosmetics, skincare, haircare, oral care, sun protection, and soaps. Food & Nutrition: IMCD offers a wide range of raw materials, ingredients, and additives for the food and beverage industry. This includes various ingredients such as emulsifiers, stabilizers, acid regulators, dyes, sweeteners, flavors, and dietary supplements. Products: IMCD offers a wide range of products used in various industries. In addition to the mentioned categories, IMCD also distributes solutions for the industrial sector, construction chemistry, environment, and energy. Their products include specialty chemicals, raw materials, formulations, and additives for all application areas, as well as technical manufacturing process and application technology, as well as laboratory and test reports. Some of the most well-known brands in their portfolio include Evonik, Huntsman, DSM, Solvay, and L'Oréal. In summary, IMCD is an important distributor and partner for numerous companies worldwide. With a diverse product portfolio and technical know-how, they support their customers in the development and production of innovative solutions. IMCD is one of the most popular companies on Eulerpool.

Frequently Asked Questions about IMCD stock

EV/EBITDA (Enterprise Value to EBITDA) of IMCD is 14.18 in 2026.

EV/EBITDA (Enterprise Value to EBITDA) of IMCD changed from 11.74 to 14.18, representing a 20.82% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/EBITDA (Enterprise Value to EBITDA) IMCD since 2006 – with annual values, charts, and detailed analysis.

The EV/EBITDA ratio is a widely used valuation metric that compares a company's enterprise value to its EBITDA. It normalizes for differences in capital structure, taxation, and depreciation policies.

To evaluate EV/EBITDA (Enterprise Value to EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBITDA (Enterprise Value to EBITDA).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBITDA (Enterprise Value to EBITDA)'s IMCD with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — IMCD

All Key Metrics — IMCD